Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FDC   ACTAVIS
EQUITY SHARE DATA
    FDC
Mar-23
ACTAVIS
Dec-18
FDC/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs31816,126-   
Low Rs22910,818-   
Sales per share (Unadj.) Rs107.53,955.8-  
Earnings per share (Unadj.) Rs11.7-1,274.2-  
Cash flow per share (Unadj.) Rs14.0416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs119.516,315.7-  
Shares outstanding (eoy) m165.91332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.53.4 74.7%   
Avg P/E ratio x23.4-10.6 -221.4%  
P/CF ratio (eoy) x19.532.3 60.3%  
Price / Book Value ratio x2.30.8 277.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m45,3684,480,758 1.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m3,9090-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m17,8381,315,689 1.4%  
Other income Rs m51225,160 2.0%   
Total revenues Rs m18,3501,340,849 1.4%   
Gross profit Rs m2,49634,478 7.2%  
Depreciation Rs m389562,428 0.1%   
Interest Rs m4175,923 0.1%   
Profit before tax Rs m2,578-578,713 -0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m640-7,334 -8.7%   
Profit after tax Rs m1,938-423,784 -0.5%  
Gross profit margin %14.02.6 534.0%  
Effective tax rate %24.81.3 1,958.2%   
Net profit margin %10.9-32.2 -33.7%  
BALANCE SHEET DATA
Current assets Rs m14,431539,627 2.7%   
Current liabilities Rs m7,296477,372 1.5%   
Net working cap to sales %40.04.7 845.4%  
Current ratio x2.01.1 175.0%  
Inventory Days Days26520 1,352.8%  
Debtors Days Days25166 378.5%  
Net fixed assets Rs m17,347148,929 11.6%   
Share capital Rs m1660-   
"Free" reserves Rs m19,6550-   
Net worth Rs m19,8205,426,601 0.4%   
Long term debt Rs m61,910,903 0.0%   
Total assets Rs m31,7968,483,012 0.4%  
Interest coverage x64.1-6.6 -967.6%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.60.2 361.7%   
Return on assets %6.2-4.1 -151.8%  
Return on equity %9.8-7.8 -125.2%  
Return on capital %13.2-4.8 -272.9%  
Exports to sales %00-   
Imports to sales %8.50-   
Net fx Rs m1,7490-   
CASH FLOW
From Operations Rs m1,549470,046 0.3%  
From Investments Rs m111258,229 0.0%  
From Financial Activity Rs m-1,800-806,740 0.2%  
Net Cashflow Rs m-138-78,073 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare FDC With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare FDC With: NORRIS MEDICINES  IPCA LABS  CONCORD DRUGS  LACTOSE INDIA  DR. REDDYS LAB  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.